ACCESS Newswire
19 Jan 2023, 23:13 GMT+10
NEW YORK, NY / ACCESSWIRE / January 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Karyopharm Therapeutics Inc. ('Karyopharm' or the 'Company') (NASDAQ:KPTI). Investors who purchased Karyopharm securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/kpti.
The investigation concerns whether Karyopharm has violated federal securities laws.
On February 8, 2022, Karyopharm reported 'successful'-though ultimately disappointing-results from its Phase 3 SIENDO Study of Xpovio for the treatment of endometrial cancer. Specifically, the treatment reduced patients' risk of disease progression or death by 30%, just barely enough to be considered statistically significant, and median progression-free survival was just 5.7 months compared to 3.8 months among patients randomized to receive a placebo. On this news, Karyopharm's stock price fell $2.05 per share, or 20.02%, to close at $8.19 per share on February 8, 2022.
Then, on March 1, 2022, Karyopharm reported negative feedback from the U.S. Food and Drug Administration ('FDA') on its supplemental NDA for Xpovio based on the Phase 3 SIENDO Study results for endometrial cancer. Specifically, the FDA found that the current results would not support NDA approval as Karyopharm and the FDA participants had differing views on the study's significance and overall clinical benefit for the whole population. On this news, Karyopharm's stock price fell $4.13 per share, or 39.75%, to close at $6.26 per share on March 2, 2022.
If you are aware of any facts relating to this investigation or purchasedKaryopharm shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/kpti. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC
Get a daily dose of Hawaii Telegraph news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Hawaii Telegraph.
More InformationDUBAI, U.A.E.: A cargo ship flagged under Liberia, known as the Eternity C, sank in the Red Sea following an attack executed by Yemen's...
WASHINGTON, D.C.: The Trump administration has started sending some weapons to Ukraine again, just a week after the Pentagon told officials...
ECAULT BEACH, France: On clear days, the white cliffs of the United Kingdom, are visible from northern France, where men, women, and...
ATLANTA, Georgia: The United States is facing its worst measles outbreak in more than three decades, with 1,288 confirmed cases so...
In the past month alone, 23 Israeli soldiers have been killed in Gaza—three more than the number of remaining living hostages held...
LONDON, U.K.: At least 13 people are believed to have taken their own lives as a result of the U.K.'s Post Office scandal, in which...
WASHINGTON, D.C.: Filmmaker Peter Jackson's lifelong fascination with the extinct giant New Zealand flightless bird called the moa...
NEW DELHI, India: India has submitted a revised proposal to the World Trade Organization (WTO) in Geneva to implement retaliatory tariffs...
SAN FRANCISCO, California: Nvidia, the Silicon Valley chipmaker at the heart of the artificial intelligence boom, this week briefly...
REDMOND, Washington: Artificial intelligence is transforming Microsoft's bottom line. The company saved over US$500 million last year...
WASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...